Nobel Prize Winner stirs the pot, science needs to archive data, and more!

Randy Scheckman (on top journals, the impact factor & open access), disappearing data, 23andMe craziness, and more…all in this edition of Blog Buzz!

Great strides made in adolescent and young adult oncology and other news

Here are a few highlights of cancer research news that have caught our attention the past two weeks:

  • The Society of Adolescent and Young Adult Oncology (SAYAO) held their first annual meeting in October 2013, in Irvine, California. SAYAO “is an international professional organization dedicated to improving adolescent and young adult cancer care through the promotion of interdisciplinary research, education, communication, and collaboration among health professionals.”
  • The journal Science published research on a new cancer cell DNA damage repair mechanism.
  • MIT biologists have discovered that tumor cells with a p53 mutation can be made more vulnerable to chemotherapy by blocking the gene MK2.
  • Researchers from the Vanderbilt-Ingram Cancer Center have discovered new molecular targets for melanoma cancer patients.

MSKCC in the News: December 1 – December 18

  • MSKCC’s Dr. Leonard Saltz was featured in a Minnesota Public Radio News broadcast about the decision by MSKCC to not stock the colon cancer drug – Zaltrap.
  • MSKCC, Fred Hutchinson Cancer Research Center, and the Seattle Children’s Research Institute have teamed up to launch Juno Therapeutics, a new cancer immunotherapy-focused biotech company.
  • Crain’s New York Business reported that MSKCC and Hunter College will move forward with their planned 1.15 million-square-foot medical complex along the FDR Drive between East 73rd and East 74th streets.